Publication | Closed Access

Clinical and Immunomodulatory Effects of Celecoxib Plus Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients with COX-2 Tumor Immunostaining

Immunomodulatory EffectsGenitourinary CancerMedicineCelecoxib Plus Interferon-alphaImmunologyPathologyImmune Checkpoint InhibitorCox-2 Tumor ImmunostainingCancer TreatmentOncologyTumor MicroenvironmentTumor Biology